The global non-opioid pain patches market is estimated to grow at a CAGR of nearly 4.5% during the forecast period. The major factors driving the market growth include the increasing number of patients with neuropathic pain and rising prevalence of cancer. Neuropathic pain occurs due to injury or malfunction in the central or peripheral nervous system. Rising incidences of spinal cord injuries and diabetes are some major causes of neuropathic pain. As per the American Diabetes Association (ADA), nearly half of all people suffering from diabetes have some kind of nerve damage and is more common in the diabetic population who are living with this disease for several years.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/non-opioid-pain-patches-market
Diabetic neuropathy can cause pain, numbness, and weakness in hands and feet. Due to the severe side-effects associated with opioid medications, the patients and healthcare professionals are looking for alternatives that can contribute to better pain management. This is leading to increasing demand for lidocaine patches, a sodium channel blocker, that may support to modulate neuropathic pain by lowering the function of these sodium channels and reversing the effects of sodium channel upregulation. These patches are used to provide relief from the pain of post-herpetic neuralgia (neuropathic pain), such as the burning, aches, or stabbing pains, that may last for months or years.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/non-opioid-pain-patches-market
Lidocaine is a group of drugs referred to as local anesthetics. It functions by stopping nerves from transmitting pain signals. As a patch, it applies to the skin only once a day as required for pain. Additionally, the prevalence of cancer is rising significantly, which results in the demand for chronic pain medications. As per the World Health Organization (WHO), in 2018, the global burden of cancer is estimated to have increased to 18.1 million new incidences and 9.6 million mortalities. Cancer pain is normally of mixed etiology, with neuropathic and nociceptive components. This, in turn, increases the need for neuropathy pain management for cancer patients. Topical lidocaine patches have been demonstrated to be effective for the treatment of postherpetic neuralgia and other painful peripheral neuropathies. Therefore, it can also be useful for pain management in cancer patients.
Market Segmentation
Global Non-Opioid Pain Patches Market by Patch Type
• Lidocaine Patches
• Diclofenac Patches
• Capsaicin Patches
• Ketoprofen Patches
• Others
Global Non-Opioid Pain Patches Market by Distribution Channel
• Hospitals
• Online Pharmacies
• Drug Stores
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• Acorda Therapeutics, Inc.
• AdhexPharma
• Alkermes plc
• Averitas Pharma, Inc.
• BioElectronics Corp.
• Ceramisphere Pty Ltd.
• Endo International plc
• GlaxoSmithKline plc
• Hisamitsu Pharmaceutical Co., Inc.
• IBSA Institut Biochimique SA
• Mylan N.V.
• Pfizer Inc.
• Sanofi S.A.
• Sorrento Therapeutics, Inc.
• TEH SENG Pharmaceutical Mfg. Co., Ltd.
• Teikoku Seiyaku Co. Ltd.
• Teva Pharmaceuticals Industries Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-opioid-pain-patches-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404